Clinical Utility of Metrics Based on Tumor Measurements in Phase II Trials to Predict Overall Survival Outcomes in Phase III Trials by Using Resampling Methods
- Citation:
- J Clin Oncol vol 33 (34) 4048-4057
- Year:
- 2015
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Pharmas:
- Grants:
- U10 CA180821, CA167326, R21 CA167326, P30 CA015083, U10 CA180882
- Corr. Author:
- Authors:
- Ming-Wen An Yu Han Jeffrey P. Meyers Jan Bogaerts Daniel J. Sargent Sumithra J. Mandrekar
- Networks:
- Study
- Alliance-A151401
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- N/A
- Keywords:
- Bios3, ORIGINAL REPORTS, Clinical Trials